This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Potassium permanganate
- DrugBank Accession Number
- DB13831
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental, Investigational
- Structure
Structure for Potassium permanganate (DB13831)
- Weight
- Average: 158.032
Monoisotopic: 157.881409 - Chemical Formula
- KMnO4
- Synonyms
- Potassium permanganate
- External IDs
- NSC-146182
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Therapies
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Antiseptic Solution Solution 5.12 g/100g Topical Grupo Salypro de Mexico, S.A. de C.V. 2021-04-01 Not applicable US 
- Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Antiseptic Solution Potassium permanganate (5.12 g/100g) Solution Topical Grupo Salypro de Mexico, S.A. de C.V. 2021-04-01 Not applicable US
Categories
- ATC Codes
- V03AB18 — Potassium permanganate
- V03AB — Antidotes
- V03A — ALL OTHER THERAPEUTIC PRODUCTS
- V03 — ALL OTHER THERAPEUTIC PRODUCTS
- V — VARIOUS
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as alkali metal permanganates. These are inorganic compounds in which the largest oxoanion is permanganate, and in which the heaviest atom not in an oxoanion is an alkali metal.
- Kingdom
- Inorganic compounds
- Super Class
- Mixed metal/non-metal compounds
- Class
- Alkali metal oxoanionic compounds
- Sub Class
- Alkali metal permanganates
- Direct Parent
- Alkali metal permanganates
- Alternative Parents
- Inorganic salts / Inorganic oxides
- Substituents
- Alkali metal permanganate / Inorganic oxide / Inorganic salt
- Molecular Framework
- Not Available
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 00OT1QX5U4
- CAS number
- 7722-64-7
- InChI Key
- VZJVWSHVAAUDKD-UHFFFAOYSA-N
- InChI
- InChI=1S/K.Mn.4O/q+1;;;;;-1
- IUPAC Name
- potassium manganesoylolate
- SMILES
- [K+].[O-][Mn](=O)(=O)=O
References
- General References
- Not Available
- External Links
- ChemSpider
- 22810
- 8604
- ChEMBL
- CHEMBL3833305
- Wikipedia
- Potassium_permanganate
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention Aspiration Pneumonia / Healthcare-associated Pneumonia (HCAP) / Nosocomial Pneumonia / Ventilator Associated Bacterial Pneumonia (VABP) 1 3 Completed Treatment Surgical Site Infections 1 1 Recruiting Treatment Coronavirus Disease 2019 (COVID‑19) / Infections, Coronavirus 1 Not Available Recruiting Prevention Abdominal Sepsis / Acute Respiratory Distress Syndrome (ARDS) / Encephalitis / Injuries, Brain / Meningitis / Pancreatitis / Seizures / Trauma Injury 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Topical 5.12 g/100g Powder Tablet - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -2.3 Chemaxon pKa (Strongest Acidic) -7 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 74.27 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 5.77 m3·mol-1 Chemaxon Polarizability 6.08 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created at June 23, 2017 20:49 / Updated at February 21, 2021 18:54